We use cookies for a better user experience. Read our Privacy Policy

I Agree

Rapid Medical Diagnostic Kits Market

Rapid Medical Diagnostic Kits Market (Application: Clinical Testing, Home Use, and Veterinary; and Technology) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

Rapid Medical Diagnostic Kits Market Outlook 2028

  • The global rapid medical diagnostic kits market was valued at US$ 14.25 Bn in 2020
  • It is estimated to expand at a CAGR of 5.3% from 2021 to 2028
  • The global rapid medical diagnostic kits market is expected to reach the value of US$ 21.78 Bn by the end of 2028

Analysts’ Viewpoint on Rapid Medical Diagnostic Kits Market Scenario

The growing demand for technologically advanced medical diagnostic kits is expected to drive the global market by creating potential revenue opportunities for market players. The significant presence of manufacturers operating in the rapid medical diagnostic kits market across the globe can be attributed to expansion into newer geographies. Manufacturers are focusing on product development using advanced techniques to stay ahead of the rising competition in the global market. In addition, the pressing need for the detection of new pathogens causing infections, along with the growing pool of elderly population that are highly susceptible to different infectious diseases, owing to a weak immune system, is mainly fueling the growth of the global market.

Impact of COVID-19 on Rapid Medical Diagnostic Kits Market

The coronavirus pandemic has caused disruption in supply chain management and logistics distribution by affecting majority of businesses across the globe. Forced lockdown, shutdown of production, and manufacturing activities have hampered the global rapid medical diagnostic kits market. Market players from the global rapid medical diagnostic kits market are recovering from the losses and focusing on re-establishing their businesses by using strategic approaches. Manufacturers are focusing on increasing the production of innovative diagnostic kits products to attract consumers across the globe. The increasing awareness about health and fitness after the threatening coronavirus pandemic can be attributed to the rapid expansion of global rapid medical diagnostic kits market.

In addition, relatively lesser cost of medical diagnostic kits and growing knowledge about the available technologies for diagnosis of infectious diseases is also boosting the market.

Request a sample to get extensive insights into the Rapid Medical Diagnostic Kits Market

Increase in Home Use Application to Drive Global Market

The global rapid medical diagnostic kits can be widely used in various applications such as clinical testing, home use, and veterinary. Clinical testing and home use applications are creating lucrative revenue opportunities for product manufacturers. Three is an increasing demand for such kits to perform blood glucose testing, fertility & pregnancy testing, substance abuse testing, cholesterol monitoring, infectious diseases testing, etc. The home use application segment is expected to account for a major share of the market during the forecast period. The ease of using technology has boosted the demand for the segment in the global rapid medical diagnostic kits market. Malaria and pregnancy test at home has proved quick turnaround for the global market and is anticipated to rise in the upcoming years.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Surge in Demand for Rapid Medical Diagnostics Kits

The rise in occurrence of infectious diseases in the past decade has been alarmingly increasing the demand for rapid medical diagnostic kits globally. The need for detecting new pathogens that are causing infections is boosting the global market. There is also a noticeable decrease in the immune system of various people due to sedentary and unhealthy lifestyle, which make them vulnerable to infections, thus, supplementing the global rapid medical diagnostic kits market.

The rise in geriatric population worldwide is also anticipated to fuel the demand for rapid medical diagnostic kits in the market. The low cost of rapid medical diagnostic kits is fueling the market rapidly. Emerging economies are also adopting rapid medical diagnostic kits due to increase in technological advancements taking place in these regions. However, due to disposable income, developed economies have already adopted the rapid medical diagnostic kits in the market. These factors are potentially increasing the demand for the global rapid medical diagnostic kits market.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Rapid Medical Diagnostic Kits Market

North America to Offer Profitable Opportunities to Rapid Medical Diagnostic Kits Market Players

North America is expected to hold the leading position in a global rapid medical diagnostic kits market during the forecast period. This region is witnessing rapid rise in growth due to increasing number of healthcare institutes adopting these diagnostic kits to detect various infectious diseases caused by bacteria and viruses. The demand in this region is followed by Europe, as it is the second-largest consumer of the rapid medical diagnostic kits market.

The Asia Pacific rapid medical diagnostic kits market is anticipated to witness high growth due to growing awareness among healthcare professionals and people about the rapid medical diagnostic tools. The market is also experiencing rise in demand due to increasing number of infectious diseases spreading across many countries.

Moreover, rise in infectious diseases in developing countries, such as African countries, is also boosting the global market.

Rapid Medical Diagnostic Kits Market: Overview

  • According to Transparency Market Research’s latest report on the global rapid medical diagnostics kits market for the historical period 2017–2028 and forecast period 2021–2028, widespread availability, aging population, and shift in technological & commercial environment are projected to drive the global rapid medical diagnostics kits market during the forecast period
  • Rapid medical diagnostics are tools for detection of various infectious diseases caused by virus and bacteria. Prevalence of infectious diseases has increased across the globe in the last decade and morbidity rate is rapidly rising.
  • Increase in detection of new pathogens-causing infections and rapid weakening of immune system due to aging are major factors driving the global rapid medical diagnostic kits market
  • Other factors propelling the global market are low cost of rapid medical diagnostic kits and increase in awareness about available technologies for diagnosis of infectious diseases

Rise in Aging Population: Major Driver

  • Aging population is one of the major factors responsible for the rise in prevalence of cardiovascular diseases, orthopedic diseases, infectious disease, neurological disorders, and endocrine diseases. This is likely to drive the demand for rapid and real-time diagnostic devices enabling continuous monitoring and instant diagnosis in the elderly population.
  • Aging is a debilitating factor, weakening the immune system and increasing the need of early and rapid diagnosis of unhealthy conditions. Surge in the geriatric population is projected to drive the demand for RDT kits during the forecast period.

Technological and Commercial Environment to Drive Global Market

  • Changes in rapid diagnostic methodology such as improvement in accuracy, ease of use, and more inclusive documentation features and quality assurance will play a vital role in propelling the demand for rapid diagnostic kits across the globe
  • Clinical factors such as need of hospital infrastructure for rapid patient turnaround is likely to increase the demand for rapid diagnostic kits. Hence, test results need to be obtained rapidly not only to save costs, but also to ease patient backlog in outpatient settings and emergency departments.
  • Rapid diagnostics are used at various sites such as sporting events, schools, camps, resorts, and other locations as these are quite portable

Rapid Medical Diagnostic Kits Market: Competition Landscape

  • This report profiles major players in the global rapid medical diagnostic kits market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • Key players in the global rapid medical diagnostic kits market include
    • Abbott Laboratories
    • Abaxis, Inc.
    • Alere, Inc.
    • Becton
    • Dickinson & Company
    • BioRad Laboratories
    • F. Hoffmann La Roche
    • MegaCor
    • Trinity Biotech
    • Zoetis, Inc.

Rapid Medical Diagnostic Kits Market: Key Developments

  • Key players in the global rapid medical diagnostic kits market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global rapid medical diagnostic kits market.
  • A few expansion strategies adopted by players operating in the global rapid medical diagnostic kits market are:
    • In 2013, Abaxis, Inc. entered into an exclusive distribution agreement with Abbott Point of Care to distribute its medical diagnostics product, Piccolo, in the U.S., China, and Hong Kong
    • In August 2013, Alere, Inc. announced the receipt of FDA clearance of its premarket approval application (PMA) for Alere Determine HIV 1/2 Ag/Ab Combo in the U.S. It is the first and the only FDA approved rapid point-of-care test that detects HIV-1 p24 antigen and both HIV-1/HIV-2 antibodies.
  • The report on the global rapid medical diagnostic kits market discussed individual strategies, followed by company profiles of manufacturers of rapid medical diagnostic kits. The competition landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global rapid medical diagnostic kits market.

Attribute

Detail

Market Size Value in 2020

US$ 14.25 Bn

Market Forecast Value in 2028

US$ 21.78 Bn

Growth Rate

5.3%

Forecast Period

2021–2028

Quantitative Units

US$ Mn for Value

Market Analysis

It includes cross segment analysis at global as well as regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview.

Competition Landscape

  • Market players – Competition matrix (by tier and size of companies)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Application
    • Clinical Testing
      • Infectious Disease Testing
      • Cholesterol Monitoring
      • Substance Abuse Testing
      • Fertility & Pregnancy Testing
      • Blood Glucose Testing
    • Home Use
      • Infectious Disease Testing
      • Cholesterol Monitoring
      • Substance Abuse Testing
      • Fertility & Pregnancy Testing
      • Blood Glucose Testing
    • Veterinary
  • Technology:
    • Lateral Flow
    • Flow-through
    • Solid-phase
    • Agglutination Assays

Regions Covered

  • North America
  • Latin America
  • Europe
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Customization Scope

Available upon request

Pricing

Available upon request

Rapid Medical Diagnostic Kits Market – Segmentation

TMR’s study on the rapid medical diagnostic kits market includes information divided into three segments: application, technology, and region. Changing industry trends and other market dynamics associated with these segments of the global rapid medical diagnostic kits market are discussed in detail.

Application
  • Clinical Testing
    • Infectious Disease Testing
    • Cholesterol Monitoring
    • Substance Abuse Testing
    • Fertility & Pregnancy Testing
    • Blood Glucose Testing
  • Home Use
    • Infectious Disease Testing
    • Cholesterol Monitoring
    • Substance Abuse Testing
    • Fertility & Pregnancy Testing
    • Blood Glucose Testing
  • Veterinary
Technology
  • Lateral Flow
  • Flow-through
  • Solid-phase
  • Agglutination Assays
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Rapid Medical Diagnostic Kits Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of rapid medical diagnostic kits market?

Rapid medical diagnostic kits market is expected to reach the value of US$ 21.78 Bn by the end of 2028

What is the anticipated CAGR of the rapid medical diagnostic kits market in the forecast period?

Rapid medical diagnostic kits market is estimated to expand at a CAGR of 5.3% from 2021 to 2028

What are the key driving factors for the growth of the rapid medical diagnostic kits market?

Rapid medical diagnostic kits market is driven by growing demand for technologically advanced medical diagnostic kits

Which is the rising prominent segment in the rapid medical diagnostic kits market?

The home use application segment is expected to account for a major share of the rapid medical diagnostic kits market during the forecast period

Who are the key players in the global rapid medical diagnostic kits market?

Key players in the global rapid medical diagnostic kits market include Abbott Laboratories, Abaxis, Inc., Alere, Inc., Becton, Dickinson & Company

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Rapid Medical Diagnostic Kits Market

4. Market Overview

    4.1. Introduction

        4.1.1. Segment Definition

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Rapid Medical Diagnostic Kits Market Analysis and Forecast, 2017–2028

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Technological Advancements

    5.2. Pipeline Analysis

    5.3. Key Mergers & Acquisitions

    5.4. COVID-19 Pandemic's Impact on Industry (value chain and short / mid / long term impact)

6. Global Rapid Medical Diagnostic Kits Market Analysis and Forecast, By Application

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Application, 2017–2028

        6.3.1. Clinical Testing

            6.3.1.1. Infectious Disease Testing

            6.3.1.2. Cholesterol Monitoring

            6.3.1.3. Substance Abuse Testing

            6.3.1.4. Fertility & Pregnancy Testing

            6.3.1.5. Blood Glucose Testing

        6.3.2. Home Use

            6.3.2.1. Infectious Disease Testing

            6.3.2.2. Cholesterol Monitoring

            6.3.2.3. Substance Abuse Testing

            6.3.2.4. Fertility & Pregnancy Testing

            6.3.2.5. Blood Glucose Testing

        6.3.3. Veterinary

    6.4. Market Attractiveness By Application

7. Global Rapid Medical Diagnostic Kits Market Analysis and Forecast, By Technology

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Technology, 2017–2028

        7.3.1. Lateral Flow

        7.3.2. Flow-through

        7.3.3. Solid-phase

        7.3.4. Agglutination Assays

    7.4. Market Attractiveness Analysis, By Technology

8. Global Rapid Medical Diagnostic Kits Market Analysis and Forecast, By Region

    8.1. Key Findings

    8.2. Market Value Forecast, by Region

        8.2.1. North America

        8.2.2. Europe

        8.2.3. Asia Pacific

        8.2.4. Latin America

        8.2.5. Middle East & Africa

    8.3. Market Attractiveness Analysis, By Region

9. North America Rapid Medical Diagnostic Kits Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. Market Value Forecast, by Application, 2017–2028

        9.2.1. Clinical Testing

            9.2.1.1. Infectious Disease Testing

            9.2.1.2. Cholesterol Monitoring

            9.2.1.3. Substance Abuse Testing

            9.2.1.4. Fertility & Pregnancy Testing

            9.2.1.5. Blood Glucose Testing

        9.2.2. Home Use

            9.2.2.1. Infectious Disease Testing

            9.2.2.2. Cholesterol Monitoring

            9.2.2.3. Substance Abuse Testing

            9.2.2.4. Fertility & Pregnancy Testing

            9.2.2.5. Blood Glucose Testing

        9.2.3. Veterinary

    9.3. Market Value Forecast, by Technology, 2017–2028

        9.3.1. Lateral Flow

        9.3.2. Flow-through

        9.3.3. Solid-phase

        9.3.4. Agglutination Assays

    9.4. Market Value Forecast, by Country, 2017–2028

        9.4.1. U.S.

        9.4.2. Canada

    9.5. Market Attractiveness Analysis

        9.5.1. By Application

        9.5.2. By Technology

        9.5.3. By Country

10. Europe Rapid Medical Diagnostic Kits Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Application, 2017–2028

        10.2.1. Clinical Testing

            10.2.1.1. Infectious Disease Testing

            10.2.1.2. Cholesterol Monitoring

            10.2.1.3. Substance Abuse Testing

            10.2.1.4. Fertility & Pregnancy Testing

            10.2.1.5. Blood Glucose Testing

        10.2.2. Home Use

            10.2.2.1. Infectious Disease Testing

            10.2.2.2. Cholesterol Monitoring

            10.2.2.3. Substance Abuse Testing

            10.2.2.4. Fertility & Pregnancy Testing

            10.2.2.5. Blood Glucose Testing

        10.2.3. Veterinary

    10.3. Market Value Forecast, by Technology, 2017–2028

        10.3.1. Lateral Flow

        10.3.2. Flow-through

        10.3.3. Solid-phase

        10.3.4. Agglutination Assays

    10.4. Market Value Forecast, by Country/Sub-Region, 2017–2028

        10.4.1. Germany

        10.4.2. U.K.

        10.4.3. France

        10.4.4. Spain

        10.4.5. Italy

        10.4.6. Rest of Europe

    10.5. Market Attractiveness Analysis

        10.5.1. By Application

        10.5.2. By Technology

        10.5.3. By Country/Sub-Region

11. Asia Pacific Rapid Medical Diagnostic Kits Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Application, 2017–2028

        11.2.1. Clinical Testing

            11.2.1.1. Infectious Disease Testing

            11.2.1.2. Cholesterol Monitoring

            11.2.1.3. Substance Abuse Testing

            11.2.1.4. Fertility & Pregnancy Testing

            11.2.1.5. Blood Glucose Testing

        11.2.2. Home Use

            11.2.2.1. Infectious Disease Testing

            11.2.2.2. Cholesterol Monitoring

            11.2.2.3. Substance Abuse Testing

            11.2.2.4. Fertility & Pregnancy Testing

            11.2.2.5. Blood Glucose Testing

        11.2.3. Veterinary

    11.3. Market Value Forecast, by Technology, 2017–2028

        11.3.1. Lateral Flow

        11.3.2. Flow-through

        11.3.3. Solid-phase

        11.3.4. Agglutination Assays

    11.4. Market Value Forecast, by Country/Sub-Region, 2017–2028

        11.4.1. China

        11.4.2. Japan

        11.4.3. India

        11.4.4. Australia & New Zealand

        11.4.5. Rest of Asia Pacific

    11.5. Market Attractiveness Analysis

        11.5.1. By Application

        11.5.2. By Technology

        11.5.3. By Country/Sub-Region

12. Latin America Rapid Medical Diagnostic Kits Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Application, 2017–2028

        12.2.1. Clinical Testing

            12.2.1.1. Infectious Disease Testing

            12.2.1.2. Cholesterol Monitoring

            12.2.1.3. Substance Abuse Testing

            12.2.1.4. Fertility & Pregnancy Testing

            12.2.1.5. Blood Glucose Testing

        12.2.2. Home Use

            12.2.2.1. Infectious Disease Testing

            12.2.2.2. Cholesterol Monitoring

            12.2.2.3. Substance Abuse Testing

            12.2.2.4. Fertility & Pregnancy Testing

            12.2.2.5. Blood Glucose Testing

        12.2.3. Veterinary

    12.3. Market Value Forecast, by Technology, 2017–2028

        12.3.1. Lateral Flow

        12.3.2. Flow-through

        12.3.3. Solid-phase

        12.3.4. Agglutination Assays

    12.4. Market Value Forecast, by Country/Sub-Region, 2017–2028

        12.4.1. Brazil

        12.4.2. Mexico

        12.4.3. Rest of Latin America

    12.5. Market Attractiveness Analysis

        12.5.1. By Application

        12.5.2. By Technology

        12.5.3. By Country/Sub-Region

13. Middle East & Africa Rapid Medical Diagnostic Kits Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Application, 2017–2028

        13.2.1. Clinical Testing

            13.2.1.1. Infectious Disease Testing

            13.2.1.2. Cholesterol Monitoring

            13.2.1.3. Substance Abuse Testing

            13.2.1.4. Fertility & Pregnancy Testing

            13.2.1.5. Blood Glucose Testing

        13.2.2. Home Use

            13.2.2.1. Infectious Disease Testing

            13.2.2.2. Cholesterol Monitoring

            13.2.2.3. Substance Abuse Testing

            13.2.2.4. Fertility & Pregnancy Testing

            13.2.2.5. Blood Glucose Testing

        13.2.3. Veterinary

    13.3. Market Value Forecast, by Technology, 2017–2028

        13.3.1. Lateral Flow

        13.3.2. Flow-through

        13.3.3. Solid-phase

        13.3.4. Agglutination Assays

    13.4. Market Value Forecast, by Country/Sub-Region, 2017–2028

        13.4.1. GCC Countries

        13.4.2. South Africa

        13.4.3. Rest of Middle East & Africa

    13.5. Market Attractiveness Analysis

        13.5.1. By Application

        13.5.2. By Technology

        13.5.3. By Country/Sub-Region

14. Competition Landscape

    14.1. Market Player - Competition Matrix (by tier and size of companies)

    14.2. Company Profiles

        14.2.1. Abbott Laboratories

            14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)            

            14.2.1.2. Product Portfolio

            14.2.1.3. Financial Overview

            14.2.1.4. Strategic Overview

            14.2.1.5. SWOT Analysis

        14.2.2. Abaxis, Inc.

            14.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)            

            14.2.2.2. Product Portfolio

            14.2.2.3. Financial Overview

            14.2.2.4. Strategic Overview

            14.2.2.5. SWOT Analysis

        14.2.3. Alere, Inc.

            14.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)            

            14.2.3.2. Product Portfolio

            14.2.3.3. Financial Overview

            14.2.3.4. Strategic Overview

            14.2.3.5. SWOT Analysis

        14.2.4. Becton Dickinson & Company

            14.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)            

            14.2.4.2. Product Portfolio

            14.2.4.3. Financial Overview

            14.2.4.4. Strategic Overview

            14.2.4.5. SWOT Analysis

        14.2.5. BioRad Laboratories

            14.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)            

            14.2.5.2. Product Portfolio

            14.2.5.3. Financial Overview

            14.2.5.4. Strategic Overview

            14.2.5.5. SWOT Analysis

        14.2.6. F. Hoffmann La Roche

            14.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)            

            14.2.6.2. Product Portfolio

            14.2.6.3. Financial Overview

            14.2.6.4. Strategic Overview

            14.2.6.5. SWOT Analysis

        14.2.7. MegaCor

            14.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)            

            14.2.7.2. Product Portfolio

            14.2.7.3. Financial Overview

            14.2.7.4. Strategic Overview

            14.2.7.5. SWOT Analysis

        14.2.8. Trinity Biotech

            14.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)            

            14.2.8.2. Product Portfolio

            14.2.8.3. Financial Overview

            14.2.8.4. Strategic Overview

            14.2.8.5. SWOT Analysis

        14.2.9. Zoetis, Inc.

            14.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)            

            14.2.9.2. Product Portfolio

            14.2.9.3. Financial Overview

            14.2.9.4. Strategic Overview

            14.2.9.5. SWOT Analysis

        14.2.10. Other prominent players

            14.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)            

            14.2.10.2. Product Portfolio

            14.2.10.3. Financial Overview

            14.2.10.4. Strategic Overview

            14.2.10.5. SWOT Analysis

List of Tables

Table 01: Global Rapid Medical Diagnostic Kits Market Value (US$ Mn) Forecast, by Application, 2017‒2031

Table 02: Global Rapid Medical Diagnostic Kits Market Value (US$ Mn) Forecast, by Clinical Testing, 2017‒2031

Table 03: Global Rapid Medical Diagnostic Kits Market Value (US$ Mn) Forecast, by Home Use, 2017‒2031

Table 04: Global Rapid Medical Diagnostic Kits Market Value (US$ Mn) Forecast, by Region, 2017‒2031

Table 05: North America Rapid Medical Diagnostic Kits Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 06: North America Rapid Medical Diagnostic Kits Market Value (US$ Mn) Forecast, by Clinical Testing, 2017‒2031

Table 07: North America Rapid Medical Diagnostic Kits Market Value (US$ Mn) Forecast, by Home Use, 2017‒2031

Table 08: Europe Rapid Medical Diagnostic Kits Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 09: Europe Rapid Medical Diagnostic Kits Market Value (US$ Mn) Forecast, by Clinical Testing, 2017‒2031

Table 10: Europe Rapid Medical Diagnostic Kits Market Value (US$ Mn) Forecast, by Home Use, 2017‒2031

Table 11: Asia Pacific Rapid Medical Diagnostic Kits Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 12: Asia Pacific Rapid Medical Diagnostic Kits Market Value (US$ Mn) Forecast, by Clinical Testing, 2017‒2031

Table 13: Asia Pacific Rapid Medical Diagnostic Kits Market Value (US$ Mn) Forecast, by Home Use, 2017‒2031

Table 14: Latin America Rapid Medical Diagnostic Kits Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 15: Latin America Rapid Medical Diagnostic Kits Market Value (US$ Mn) Forecast, by Clinical Testing, 2017‒2031

Table 16: Latin America Rapid Medical Diagnostic Kits Market Value (US$ Mn) Forecast, by Home Use, 2017‒2031

Table 17: Middle East & Africa Rapid Medical Diagnostic Kits Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 18: Middle East & Africa Rapid Medical Diagnostic Kits Market Value (US$ Mn) Forecast, by Clinical Testing, 2017‒2031

Table 19: Middle East & Africa Rapid Medical Diagnostic Kits Market Value (US$ Mn) Forecast, by Home Use, 2017‒2031

List of Figures

Figure 01: Global Rapid Medical Diagnostic Kits Market Value (US$ Mn) Forecast, 2017–2028

Figure 02: Global Rapid Medical Diagnostic Kits Market Value Share, by Application, 2020

Figure 03: Global Rapid Medical Diagnostic Kits Market Value Share, by Technology – Use, 2020

Figure 04: Global Rapid Medical Diagnostic Kits Market Value Share Analysis, by Application, 2020 and 2028

Figure 05: Global Rapid Medical Diagnostic Kits Market Attractiveness Analysis, by Application, 2017–2028

Figure 06: Global Rapid Medical Diagnostic Kits Market Value (US$ Mn), by Clinical Testing, 2017–2028

Figure 07: Global Rapid Medical Diagnostic Kits Market Value (US$ Mn), by Home Use, 2017–2028

Figure 08: Global Rapid Medical Diagnostic Kits Market Value (US$ Mn), by Veterinary, 2017–2028

Figure 09: Global Rapid Medical Diagnostic Kits Market Value Share Analysis, by Technology, 2020 and 2028

Figure 10: Global Rapid Medical Diagnostic Kits Market Attractiveness Analysis, by Technology, 2017–2028

Figure 11: Global Rapid Medical Diagnostic Kits Market Value (US$ Mn), by Lateral Flow, 2017–2028

Figure 12: Global Rapid Medical Diagnostic Kits Market Value (US$ Mn), by Flow-through, 2017–2028

Figure 13: Global Rapid Medical Diagnostic Kits Market Value (US$ Mn), by Solid-phase, 2017–2028

Figure 14: Global Rapid Medical Diagnostic Kits Market Value (US$ Mn), by Agglutination Assays, 2017–2028

Figure 15: Global Rapid Medical Diagnostic Kits Market Value Share Analysis, by Region, 2020 and 2028

Figure 16: Global Rapid Medical Diagnostic Kits Market Attractiveness Analysis, by Region, 2017–2028

Figure 17: North America Rapid Medical Diagnostic Kits Market Value (US$ Mn) Forecast, 2017–2028

Figure 18: North America Rapid Medical Diagnostic Kits Market Value Share Analysis, Application, 2020 and 2028

Figure 19: North America Rapid Medical Diagnostic Kits Market Attractiveness Analysis, by Application, 2017–2028 

Figure 20: North America Rapid Medical Diagnostic Kits Market Value Share Analysis, by Technology, 2020 and 2028

Figure 21: North America Rapid Medical Diagnostic Kits Market Attractiveness Analysis, by Technology, 2017–2028

Figure 22: North America Rapid Medical Diagnostic Kits Market Value Share Analysis, by Country, 2020 and 2028

Figure 23: North America Rapid Medical Diagnostic Kits Market Attractiveness Analysis, by Country, 2017–2028

Figure 24: Europe Rapid Medical Diagnostic Kits Market Value (US$ Mn) Forecast, 2017–2028

Figure 25: Europe Rapid Medical Diagnostic Kits Market Value Share Analysis, Application, 2020 and 2028

Figure 26: Europe Rapid Medical Diagnostic Kits Market Attractiveness Analysis, by Application, 2017–2028 

Figure 27: Europe Rapid Medical Diagnostic Kits Market Value Share Analysis, by Technology, 2020 and 2028

Figure 28: Europe Rapid Medical Diagnostic Kits Market Attractiveness Analysis, by Technology, 2017–2028

Figure 29: Europe Rapid Medical Diagnostic Kits Market Value Share Analysis, by Country/Sub-Region, 2020 and 2028

Figure 30: Europe Rapid Medical Diagnostic Kits Market Attractiveness Analysis, by Country/Sub-Region, 2017–2028

Figure 31: Asia Pacific Rapid Medical Diagnostic Kits Market Value (US$ Mn) Forecast, 2017–2028

Figure 32: Asia Pacific Rapid Medical Diagnostic Kits Market Value Share Analysis, Application, 2020 and 2028

Figure 33: Asia Pacific Rapid Medical Diagnostic Kits Market Attractiveness Analysis, by Application, 2017–2028 

Figure 34: Asia Pacific Rapid Medical Diagnostic Kits Market Value Share Analysis, by Technology, 2020 and 2028

Figure 35: Asia Pacific Rapid Medical Diagnostic Kits Market Attractiveness Analysis, by Technology, 2017–2028

Figure 36: Asia Pacific Rapid Medical Diagnostic Kits Market Value Share Analysis, by Country/Sub-Region, 2020 and 2028

Figure 37 Asia Pacific Rapid Medical Diagnostic Kits Market Attractiveness Analysis, by Country/Sub-Region, 2017–2028

Figure 38: Latin America Rapid Medical Diagnostic Kits Market Value (US$ Mn) Forecast, 2017–2028

Figure 39: Latin America Rapid Medical Diagnostic Kits Market Value Share Analysis, Application, 2020 and 2028

Figure 40: Latin America Rapid Medical Diagnostic Kits Market Attractiveness Analysis, by Application, 2017–2028 

Figure 41: Latin America Rapid Medical Diagnostic Kits Market Value Share Analysis, by Technology, 2020 and 2028

Figure 42: Latin America Rapid Medical Diagnostic Kits Market Attractiveness Analysis, by Technology, 2017–2028

Figure 43: Latin America Rapid Medical Diagnostic Kits Market Value Share Analysis, by Country/Sub-Region, 2020 and 2028

Figure 44: Latin America Rapid Medical Diagnostic Kits Market Attractiveness Analysis, by Country/Sub-Region, 2017–2028

Figure 45: Middle East & Africa Rapid Medical Diagnostic Kits Market Value (US$ Mn) Forecast, 2017–2028

Figure 46: Middle East & Africa Rapid Medical Diagnostic Kits Market Value Share Analysis, Application, 2020 and 2028

Figure 47: Middle East & Africa Rapid Medical Diagnostic Kits Market Attractiveness Analysis, by Application, 2017–2028 

Figure 48: Middle East & Africa Rapid Medical Diagnostic Kits Market Value Share Analysis, by Technology, 2020 and 2028

Figure 49: Middle East & Africa Rapid Medical Diagnostic Kits Market Attractiveness Analysis, by Technology, 2017–2028

Figure 50: Middle East & Africa Rapid Medical Diagnostic Kits Market Value Share Analysis, by Country/Sub-Region, 2020 and 2028

Figure 51: Middle East & Africa Rapid Medical Diagnostic Kits Market Attractiveness Analysis, by Country/Sub-Region, 2017–2028

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

848

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved